COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
Nanoparticle drug deliveryAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Mr Xiong HE. Nanotechnology could be strategically implemented in new developing drug delivery systems that can expand drug markets. Such a plan would be applied to drugs selected for full-scale development based on their safety and efficacy data, but which fail to reach clinical development because of poor biopharmacological properties, for example, poor solubility or poor permeability across the intestinal epithelium, situations that translate into poor bioavailability and undesirable pharmacokinetic properties. The new drug delivery methods are expected to enable pharmaceutical companies to reformulate existing drugs on the market, thereby extending the lifetime of products and enhancing the performance of drugs by increasing effectiveness, safety and patient adherence, and ultimately reducing healthcare costs. This talk is part of the COCA Talks series. This talk is included in these lists:Note that ex-directory lists are not shown. |
Other listsMr Keynes and the Moderns The Sackler Lectures Cambridge University Physics Society The obesity epidemic: Discussing the global health crisis Andrew Chamblin Memorial Lecture 2015 Stone LecturesOther talksEthics for the working mathematician, seminar 10: Mathematicians being leaders. CANCELLED First year PhD student fieldwork seminar What constitutes 'discrimination' in everyday talk? Argumentative lines and the social representations of discrimination What we don’t know about the Universe from the very small to the very big : ONE DAY MEETING Hide and seek: medieval creatures on the manuscript page Group covariance functions for Gaussian process metamodels with categorical inputs |